Pupillo E et al (2014) Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol 75(2):287–297
Hardiman O et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Prim 3(1):1–19
Menke RAL et al (2014) Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain 137(Pt 9):2546–2555
Article PubMed PubMed Central Google Scholar
Agosta F et al (2012) The cortical signature of amyotrophic lateral sclerosis. PLoS One 7(8):1–8
D’Ambrosio A et al (2014) Frontotemporal cortical thinning in amyotrophic lateral sclerosis. Am J Neuroradiol 35(2):304–310
Article PubMed PubMed Central Google Scholar
Cirillo M et al (2012) Widespread microstructural white matter involvement in amyotrophic lateral sclerosis: a whole-brain DTI study. AJNR Am J Neuroradiol 33(6):1102–1108
Article CAS PubMed PubMed Central Google Scholar
Kasper E et al (2014) Microstructural White matter changes underlying cognitive and behavioural impairment in ALS—an in vivo study using DTI. PLoS One 9(12):e114543
Article PubMed PubMed Central Google Scholar
Floeter MK, Bageac D, Danielian LE, Braun LE, Traynor BJ, Kwan JY (2016) Longitudinal imaging in C9orf72 mutation carriers: relationship to phenotype. NeuroImage Clin 12:1035–1043
Article PubMed PubMed Central Google Scholar
Van Der Graaff MM et al (2011) Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study. Brain 134(4):1211–1228
Floeter MK, Danielian LE, Braun LE, Wu T (2018) Longitudinal diffusion imaging across the C9orf72 clinical spectrum. J Neurol Neurosurg Psychiatry 89(1):53–60
Schuster C et al (2014) Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiol Aging 35(1):240–246
Walhout R et al (2015) Cortical thickness in ALS: towards a marker for upper motor neuron involvement. J Neurol Neurosurg Psychiatry 86(3):288–294
Kassubek J et al (2018) Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker. J Neurol Neurosurg Psychiatry 89(4):374–381
Meier JM et al (2020) Connectome-based propagation model in amyotrophic lateral sclerosis. Ann Neurol 87(5):725–738
Article PubMed PubMed Central Google Scholar
Querin G et al (2019) Presymptomatic spinal cord pathology in c9orf72 mutation carriers: a longitudinal neuroimaging study. Ann Neurol 86(2):158–167
Article CAS PubMed Google Scholar
Kassner A, Thornhill RE (2010) Texture analysis: a review of neurologic MR imaging applications. Am J Neuroradiol 31(5):809–816
Article CAS PubMed PubMed Central Google Scholar
Haralick RM, Dinstein I, Shanmugam K (1973) Textural features for image classification. IEEE Trans Syst Man Cybern 3(6):610–621
Maani R, Yang YH, Kalra S (2015) Voxel-based texture analysis of the brain. PLoS One 10(3):e0117759
Article PubMed PubMed Central Google Scholar
Ishaque A et al (2018) Texture analysis to detect cerebral degeneration in amyotrophic lateral sclerosis. Can J Neurol Sci 45(5):533–539
Ishaque A et al (2019) Corticospinal tract degeneration in ALS unmasked in T1-weighted images using texture analysis. Hum Brain Mapp 40(4):1174–1183
Ishaque A et al (2022) Distinct patterns of progressive gray and white matter degeneration in amyotrophic lateral sclerosis. Hum Brain Mapp 43(5):1519–1534
Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) “El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis”, Amyotroph. Lateral Scler Other Motor Neuron Disord 1(5):293–9
Cedarbaum JM et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169(1–2):13–21
Article CAS PubMed Google Scholar
Roche JC et al (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135(3):847–852
Article PubMed PubMed Central Google Scholar
Balendra R et al (2014) Estimating clinical stage of amyotrophic lateral sclerosis from the ALS functional rating scale. Amyotroph Lateral Scler Front Degener 15(3–4):279–284
Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Front Degener 15(1–2):9–14
Bensimon G, Lacomblez L, Meininger V (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330(9):585–591
Article CAS PubMed Google Scholar
Abe K et al (2017) Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 16(7):505–512
Ta D et al (2021) Progressive neurochemical abnormalities in cognitive and motor subgroups of amyotrophic lateral sclerosis. Neurology 97(8):e803
Article CAS PubMed PubMed Central Google Scholar
Fang T et al (2017) Comparison of the King’s and MiToS staging systems for ALS. Amyotroph Lateral Scler Frontotemporal Degener 18(3–4):227
Article PubMed PubMed Central Google Scholar
Kalra S et al (2020) The Canadian ALS Neuroimaging Consortium (CALSNIC)-a multicentre platform for standardized imaging and clinical studies in ALS. medRxiv. https://doi.org/10.1101/2020.07.10.20142679
Gaser C, Dahnke R (2016) CAT-A computational anatomy toolbox for the analysis of structural MRI data. biorxiv. https://doi.org/10.1101/2022.06.11.495736
Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38(1):95–113
Fortin JP et al (2017) Harmonization of multi-site diffusion tensor imaging data. Neuroimage 161:149–170
Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8(1):118–127
Tahedl M et al (2023) Brainstem–cortex disconnection in amyotrophic lateral sclerosis: bulbar impairment, genotype associations, asymptomatic changes and biomarker opportunities. J Neurol 270(7):3511–3526
Article PubMed PubMed Central Google Scholar
Hughes JT (1982) Pathology of amyotrophic lateral sclerosis. Adv Neurol 36:61–74
Turner MR, Agosta F, Bede P, Govind V, Lulé D, Verstraete E (2012) Neuroimaging in amyotrophic lateral sclerosis. Biomark Med 6(3):319–337
Article CAS PubMed Google Scholar
Uddin LQ, Nomi JS, Hébert-Seropian B, Ghaziri J, Boucher O (2017) Structure and function of the human insula. J Clin Neurophysiol. https://doi.org/10.1097/WNP.0000000000000377
Article PubMed PubMed Central Google Scholar
Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284(30):20329–20339
Article CAS PubMed PubMed Central Google Scholar
Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501(7465):45–51
Article CAS PubMed PubMed Central Google Scholar
Verstraete E, Veldink JH, Hendrikse J, Schelhaas HJ, Van Den Heuvel MP, Van Den Berg LH (2012) Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 83(4):383–388
留言 (0)